WWP
ABBV icon

Waypoint Wealth Partners’s AbbVie ABBV Stock Holding History

Waypoint Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$443K Buy
2,388
+992
+71% +$184K 0.11% 54
2025
Q1 		$292K Sell
1,396
-771
-36% -$150K 0.08% 54
2024
Q4 		$385K Hold
2,167
– – 0.11% 52
2024
Q3 		$428K Buy
2,167
+847
+64% +$158K 0.11% 52
2024
Q2 		$226K Sell
1,320
-20
-1% -$3.31K 0.07% 59
2024
Q1 		$244K Buy
+1,340
New +$231K 0.07% 66

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Waypoint Wealth Partners's ABBV Position: Q2 2025 in Review

Waypoint Wealth Partners increased its AbbVie (ABBV) stake by 71% in Q2 2025, buying an estimated $184K and bringing the position to 2,388 shares worth $443K. The position accounts for 0.11% of the portfolio, ranked #54.

Waypoint Wealth Partners first reported a position in ABBV in Q1 2024 and has held it in 6 quarters since. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Waypoint Wealth Partners held 2,388 shares of AbbVie worth $443K as of Q2 2025.
  • Waypoint Wealth Partners bought 992 AbbVie shares in Q2 2025, an estimated $184K.
  • AbbVie made up 0.11% of Waypoint Wealth Partners's portfolio in Q2 2025, its #54 holding.
  • Waypoint Wealth Partners first reported a position in AbbVie in Q1 2024 and has held it in 6 quarters since.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Waypoint Wealth Partners's 13F filing for Q2 2025, filed 10 Jul 2025.